* CELLIAL TECHNOLOGIES *
2001 - North-Picardie Lens www.cellial.com Contract, Research Key words: CNS research optimization, In vitro cell culture, Blood-Brain Barrier Mission: accelerate CNS profiling and identify qualified leads candidates and eliminates the botleneck of drug transport accross Blood-Brain Barrier from clients' discovery process Clients: Pharmaceutical industry, Biotechs, Academic labs contact@cellial.com
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS | | Personal venture | Managing Dir.: Wendzinski (Yves) [Eng. ISEN] Sc.Dir.: Berezowski (Vincent) [Ph.D.] Fin.Dir.: BusDev: Financers: Finorpa, Nord Innovation, Innovam Communication: no website news update since 2005 in October 2008 | Turnover (M€) : 0.4 (2004) Total funding (M€) : 1.0 Last funding (M€) : 1.0 Focus : Multiple Position : Subcontractor Company confirm : none |
History | DATE | MILESTONE | TYPE | TIME | | 2002 .10 | Nomination : Yves Wendzinski as CEO (also Chairman), replacing Michel Major | ORGN | [1 year] |
| 2002 .11 | 1st round-financing : 1.0 M€, by Finorpa, Nord Innovation, Innovam | RFINA | [1 year] |
| 2001 .01 | Company founded by Prof. Romeo Cecchelli (Institut Pasteur Lille), within Eurasanté Bio-incubator | ORGF | [0 year] | Actualisation / Updating: 31-Oct-2008 |
|